C WorldWide Group’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Other funds holding NBIX
C WorldWide Group's NBIX Position: Q3 2026 in Review
C WorldWide Group held its Neurocrine Biosciences (NBIX) position steady in Q3 2026 at 125,000 shares worth $17.7M. The position accounts for 0.45% of the portfolio, ranked #36.
C WorldWide Group first reported a position in NBIX in Q2 2024 and has held it in 10 quarters since. The position peaked at $21.1M in Q2 2026. 767 funds tracked by Wall St. Rank hold NBIX as of Q3 2026.
- C WorldWide Group held 125,000 shares of Neurocrine Biosciences worth $17.7M as of Q3 2026.
- C WorldWide Group left its Neurocrine Biosciences share count unchanged in Q3 2026.
- Neurocrine Biosciences made up 0.45% of C WorldWide Group's portfolio in Q3 2026, its #36 holding.
- C WorldWide Group first reported a position in Neurocrine Biosciences in Q2 2024 and has held it in 10 quarters since.
- C WorldWide Group's Neurocrine Biosciences position peaked at $21.1M in Q2 2026.
- 767 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q3 2026.
Based on C WorldWide Group's 13F filing for Q3 2026, filed 4 Nov 2026.